InvestorsHub Logo
Followers 19
Posts 817
Boards Moderated 0
Alias Born 12/12/2016

Re: NWDR post# 122413

Thursday, 09/28/2017 10:04:39 PM

Thursday, September 28, 2017 10:04:39 PM

Post# of 463053
Excellent perspective & analysis NWDR; thank you for your post.

And Xena and others have explained & highlighted the various MM & HFT methods of controlling the price action in this low volume & marginalized & relatively unknown Anavex security; NEVERTHELESS I'll admit it is head-scratching how we could still have a market cap of a company treating just 10% of the insomnia market.

Perhaps Froll's risky & tricky biotech warnings mean that us retail investors should simply:

• ignore the numerous positive signals and signs recently and the independent researchers' efficacy results from WSU for MS and MJFF's Dr Francardo for Parkinson's and
• ignore the words of Dr George Perry and
• ignore the words of Dr Andrew Cole and
• ignore the MTA interest of Biogen in our compound and
• ignore the fact that our CEO has illustrated the ULTIMATE sign of confidence with S-4 regulated insider purchases of stock and
• ignore the real world perspectives of our patients' caregivers from Australia trial (surely sugar pills induce similar responses) and
• ignore the improvement of 100% of insomnia sufferers and
• ignore the fact that our CEO continues to affirmatively assert that the compound crosses the blood brain barrier (as mild side effects only occurs near the highest 50mg dosage (excellent sign)) and
• ignore the upsloping 57 week cognition improvements on the MMSE and ADCS-ADL and P300 amplitude charts that the Company is STANDING BY TO THIS DAY and
• ignore the fact that the Company CONTINUES to represent their affirmative and unambiguous claims of "restores cellular homeostasis" and "provides dose dependent cognitive improvement" and
• ignore the fact that the mainstream media/biotech analysts and BP funded researchers are not interested in publicly discussing the Anavex MOA and its unique approach towards battling CNS diseases as they are, and will continue to be, reticent to admit that smallcap Anavex has the promise that they have failed to achieve (after billions & decades of failed tau protein removal efforts)


EOM. All must DYODD. I was at best a B student in science. This communication does not constitute a recommendation to buy or sell this or any other stock. Good night.






Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News